MyFinsight
Home
Blog
About
Cash and cash
equivalents
$7,262K
(-3.90%↓ Y/Y)
Prepaid expenses and
other current assets
$1,461K
(-3.82%↓ Y/Y)
Intangible assets
$11,148K
(0.00%↑ Y/Y)
Total current assets
$8,723K
(-3.89%↓ Y/Y)
Other non-current
assets
$900K
(0.00%↑ Y/Y)
Operating lease
right-of-use asset
$254K
(-31.35%↓ Y/Y)
Furniture and equipment,
net
$62K
(-37.37%↓ Y/Y)
Total assets
$21,087K
(-2.34%↓ Y/Y)
Total liabilities and
stockholders equity
$21,087K
(-2.34%↓ Y/Y)
Total stockholders
equity
$11,587K
(261.72%↑ Y/Y)
Total liabilities
$9,500K
(-66.97%↓ Y/Y)
Accumulated deficit
-$226,484K
(-35.26%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$64K
Additional paid-in capital
$238,128K
(48.56%↑ Y/Y)
Total current
liabilities
$9,313K
(17.69%↑ Y/Y)
Operating lease liability
- long-term, net...
$147K
(-49.66%↓ Y/Y)
Warrant liability
$40K
(-99.81%↓ Y/Y)
Common stock, 0.001 par
value 500,000,000...
$7K
(-76.67%↓ Y/Y)
Accrued expenses and
other current...
$4,976K
(18.70%↑ Y/Y)
Accounts payable
$4,337K
(16.55%↑ Y/Y)
Back
Back
Balance Sheet
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX)
source: myfinsight.com